$3 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 120 reported holdings in Q2 2015. The portfolio turnover from Q1 2015 to Q2 2015 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ALLSCRIPTS HEALTHCARE SOLUTNnote 1.250% 7/0 | $103,524,000 | +4.7% | 100,750,000 | 0.0% | 3.45% | +7.7% | ||
| FLML | FLAMEL TECHNOLOGIES SAsponsored adr | $86,303,000 | +17.9% | 4,072,809 | 0.0% | 2.88% | +21.2% | |
| ARRAY BIOPHARMA INCnote 3.000% 6/0 | $56,942,000 | +1.6% | 45,000,000 | 0.0% | 1.90% | +4.5% | ||
| EHTH | EHEALTH INC | $41,428,000 | +35.3% | 3,264,588 | 0.0% | 1.38% | +39.1% | |
| ONCE | SPARK THERAPEUTICS INC | $38,042,000 | -22.2% | 631,192 | 0.0% | 1.27% | -20.0% | |
| INGN | INOGEN INC | $26,839,000 | +39.4% | 601,772 | 0.0% | 0.89% | +43.3% | |
| WEBMD HEALTH CORPnote 1.500%12/0 | $24,636,000 | +0.8% | 23,000,000 | 0.0% | 0.82% | +3.8% | ||
| ACCURAY INCnote 3.750% 8/0 | $24,565,000 | -8.0% | 24,100,000 | 0.0% | 0.82% | -5.4% | ||
| PRTO | PROTEON THERAPEUTICS INC | $22,599,000 | +53.6% | 1,265,343 | 0.0% | 0.75% | +57.9% | |
| ALIM | ALIMERA SCIENCES INC | $20,379,000 | -8.0% | 4,420,580 | 0.0% | 0.68% | -5.3% | |
| EXEL | EXELIXIS INCput | $15,040,000 | +46.3% | 4,000,000 | 0.0% | 0.50% | +50.5% | |
| JUNO | JUNO THERAPEUTICS INC | $9,767,000 | -12.1% | 183,149 | 0.0% | 0.32% | -9.7% | |
| AMPH | AMPHASTAR PHARMACEUTICALS IN | $7,885,000 | +17.5% | 448,532 | 0.0% | 0.26% | +21.2% | |
| RIGL | RIGEL PHARMACEUTICALS INC | $7,697,000 | -10.1% | 2,397,855 | 0.0% | 0.26% | -7.6% | |
| ATEC | ALPHATEC HOLDINGS INC | $6,876,000 | -4.8% | 4,982,738 | 0.0% | 0.23% | -2.1% | |
| BEAT | BIOTELEMETRY INC | $6,076,000 | +6.6% | 644,300 | 0.0% | 0.20% | +9.2% | |
| TCON | TRACON PHARMACEUTICALS INC | $5,495,000 | -19.3% | 485,000 | 0.0% | 0.18% | -17.2% | |
| STRM | STREAMLINE HEALTH SOLUTIONS | $5,104,000 | -21.1% | 1,822,759 | 0.0% | 0.17% | -19.0% | |
| CASM | CAS MED SYS INC | $4,096,000 | -4.1% | 3,200,000 | 0.0% | 0.14% | -1.4% | |
| PRQR | PROQR THRAPEUTICS N V | $3,491,000 | -23.8% | 209,398 | 0.0% | 0.12% | -21.6% | |
| NVTA | INVITAE CORP | $2,480,000 | -11.2% | 166,666 | 0.0% | 0.08% | -7.8% | |
| DSCO | DISCOVERY LABORATORIES INC N | $2,489,000 | -42.8% | 3,659,700 | 0.0% | 0.08% | -41.1% | |
| KIN | KINDRED BIOSCIENCES INC | $1,904,000 | -4.5% | 279,204 | 0.0% | 0.06% | -3.1% | |
| PTN | PALATIN TECHNOLOGIES INC | $1,780,000 | -12.7% | 2,000,000 | 0.0% | 0.06% | -10.6% | |
| CORSICANTO LTDnote 3.500% 1/1 | $1,084,000 | +3.8% | 1,000,000 | 0.0% | 0.04% | +5.9% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AERIE PHARMACEUTICALS INC | 36 | Q3 2022 | 3.6% |
| CENTENE CORP DEL | 30 | Q3 2023 | 3.0% |
| BIOCRYST PHARMACEUTICALS INC | 29 | Q3 2023 | 2.2% |
| MOLINA HEALTHCARE INC | 26 | Q3 2022 | 1.7% |
| EHEALTH INC | 25 | Q3 2020 | 2.0% |
| INTERCEPT PHARMACEUTICALS IN | 24 | Q1 2023 | 2.2% |
| MYLAN NV | 23 | Q3 2020 | 6.2% |
| PORTOLA PHARMACEUTICALS INC | 23 | Q1 2019 | 6.0% |
| BROOKDALE SR LIVING INC | 23 | Q3 2023 | 2.2% |
| ALIMERA SCIENCES INC | 23 | Q3 2019 | 0.8% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| DA32 Life Science Tech Acquisition Corp. | August 01, 2023 | 5,145,000 | 91.1% |
| CareMax, Inc. | March 13, 2023 | 18,691,423 | 16.4% |
| CareMax, Inc. | June 02, 2022 | 18,691,423 | 20.7% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 3 | 2024-03-19 |
| 4 | 2024-03-19 |
| 4 | 2024-03-12 |
| 3 | 2024-03-08 |
| 4 | 2024-02-16 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-08 |
| 3 | 2024-02-01 |
| 4 | 2023-11-21 |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.